DataMeds AI, Inc. (MEDS): Total Liabilities
$42.91M
As of 2025-12-31
$52.26M
As of 2026-06-30
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $42.91M | -15.2% | 2026-03-20, Balance as of period end |
| 2024-12-31 | $50.60M | n/m | 2026-03-20, Balance as of period end |
| 2023-12-31 | $3.24M | n/a | 2025-03-25, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| DataMeds AI, Inc. (MEDS) | 2025-12-31 | $42.91M | -15.2% |
| Cosmos Health Inc. (COSM) | 2025-12-31 | $47.05M | +58.0% |
| Stemtech Corp (STEK) | 2025-12-31 | $10.59M | +21.1% |
| Nu Skin Enterprises, Inc. (NUS) | 2025-12-31 | $600.07M | -26.6% |
| Herbalife Ltd. (HLF) | 2025-12-31 | $3.30B | -6.6% |
Compare MEDS, COSM, STEK, NUS side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗